Are you a Veteran of the United States Armed Forces?

Please complete a short survey about prostate cancer care for Veterans to help us learn what's working well and what needs improvement in the care Veterans receive.

Veterans prostate cancer care survey Complete the Survey

Modra Pharmaceuticals Starts Phase 2 Trial of Oral Docetaxel in Metastatic Prostate Cancer

Modra Pharmaceuticals has enrolled its first patient in a Phase 2 clinical trial (NCT03136640) of  ModraDoc006/r as a treatment for metastatic castration-resistant prostate cancer — an advanced and often fatal form of the disease.

Read more.

Source: Prostate Cancer News Today

Share